Cargando…
Temporal analysis of pain responders and common adverse events: when do these first appear following treatment with pregabalin
BACKGROUND: Pregabalin is an α(2)δ ligand indicated in the USA for treatment of a number of chronic pain conditions, including diabetic peripheral neuropathy, postherpetic neuralgia, pain associated with spinal cord injury, and fibromyalgia. A greater understanding of when patients first respond to...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494606/ https://www.ncbi.nlm.nih.gov/pubmed/26170712 http://dx.doi.org/10.2147/JPR.S82806 |